RGT-490

N/A

Report date: 2026/04/22 20:01:10
NME

Base Information

Drug NameRGT-490
Drug Alias NameRGT-490RGT490
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase alpha inhibitors
TargetsPhosphatidylinositol 3 kinase alpha
Therapy Area/IndicationsSolid tumoursUterine Cervical NeoplasmsEndometrial Neoplasms +[6
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaIND
Originator CompaniesQILU Regor Therapeutics Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursUterine Cervical NeoplasmsEndometrial Neoplasms +[5
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A